Growth Metrics

Nexalin Technology (NXL) EBITDA Margin Growth (3y) (2024 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin Growth (3y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -343.00
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 17.00
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -178.00
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 487.00
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -283.00
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 72.00
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 1,505.00
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -184.00
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -3,846.00
10 Nexalin Technology 11.19 Mn 8.48 Mn 13,133.00 -1.17 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -1.17 Mn
Dec 31, 2025 42,255.00
Sep 30, 2025 -1.25 Mn
Jun 30, 2025 -212,740.00
Mar 31, 2025 -472,418.00
Dec 31, 2024 -801,889.00
Sep 30, 2024 -358,789.00